CBS 2019
CBSMD教育中心
中 文

Mitral/Tricuspid Valvular Disease

Abstract

Recommended Article

Surgery Does Not Improve Survival in Patients With Isolated Severe Tricuspid Regurgitation Pathophysiology, diagnosis and new therapeutic approaches for ischemic mitral regurgitation Regurgitant Volume/Left Ventricular End-Diastolic Volume Ratio: Prognostic Value in Patients With Secondary Mitral Regurgitation A Score to Assess Mortality After Percutaneous Mitral Valve Repair Thrombotic Risk and Antithrombotic Strategies After Transcatheter Mitral Valve Replacement Potential Candidates for Transcatheter Tricuspid Valve Intervention After Transcatheter Aortic Valve Replacement: Predictors and Prognosis Impact of Transcatheter Mitral Valve Repair on Preprocedural and Postprocedural Hospitalization Rates Prevalence and clinical implications of valvular calcification on coronary computed tomography angiography

Original Research2021 Apr 6.

JOURNAL:Ann Intern Med. Article Link

In acute HF and iron deficiency, IV ferric carboxymaltose reduced HF hospitalizations, but not CV death, at 1 y

EM DeFilippis, HGC Van Spall. Keywords: anemia, iron-deficiency; ferric compounds; HF; maltose

LINK

Please click on "Article Link" to get access to this article.